Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > New Press Release - BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

View:

(0)
•••

Post by PressRelease on Feb 01, 2024 5:11pm

New Press Release - BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

VANCOUVER, BC, Feb. 1, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price...read article.

Comment

Comment by Mario79 on Feb 01, 2024 11:23pm

Hopefully there will be another news release in the works regarding the acquisition. If that happens we are back in business and things will get alot interested.

Comment

Comment by Humanist on Feb 02, 2024 9:50am

I am wondering why did they do it in tranches since it was not announced as such! alsoi believe the acquisition is dependent on the pvt palcement but is it dependent on the the whole thing or thefirst tranche is enough! who knows.. a step in the right direction but i don't feel safe yet especiall asi added shares.. glta

116

Comment

BioVaxys Technology Corp.